CAROLINE LUPERCIO: Open Payments
NPI 1750043626 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,533 in 79 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $344 · 2025 $1,533
Food & beverage: $1,533
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $264 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $243 |
| Gilead Sciences, Inc. | 9 | $222 |
| Janssen Biotech, Inc. | 15 | $183 |
| Madrigal Pharmaceuticals | 6 | $165 |
| Ardelyx, Inc. | 6 | $150 |
| Phathom Pharmaceuticals, Inc. | 7 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $66 |
| Ipsen Biopharmaceuticals, Inc | 3 | $50 |
| PFIZER INC. | 2 | $41 |
Products named: ENTYVIO, TREMFYA, RINVOQ, REZDIFFRA, IBSRELA, Livdelzi, VOQUEZNA, SKYRIZI.
Industry payments across TX — which companies pay providers there.
